ProfessorNicholas Mazarakis, FRSB

Chair MolBioMedicine and Head of Gene Therapy

Department of Brain Sciences - Faculty of Medicine

  • Chair MolBioMedicine and Head of Gene Therapy
    Department of Brain Sciences - Faculty of Medicine
  • 020 7594 7024 (Work)
  • E402, Burlington Danes, Hammersmith Campus, United Kingdom

PROFESSIONAL ACTIVITIES

  • EDITORIAL BOARD
    Frontiers Cellular Neuroscience
    5 Feb 2021
    Frontiers in Cellular Neuroscience (Cellular Neurophysiology section)
  • GUEST LECTURE
    “Towards gene therapy for a neurodevelopmental disorder: AAV gene replacement therapy in models of cdkl5 disorder” May 17-18, 2019
    18 May 2019
    Hellenic Society of Gene Therapy and Regenerative Medicine
  • GUEST LECTURE
    “Viral vectors for gene therapy and modelling of CNS diseases”
    1 Dec 2017
    27th Annual meeting of the network of European Transplantation & Restoration (NECTAR)
  • GUEST LECTURE
    “Selective vs widespread CNS gene transfer with viral vectors”
    1 Apr 2017
    BSGCT Annual Conference
  • GUEST LECTURE
    Harnessing viruses for gene therapy and modelling of neurological diseases
    28 Oct 2016
    The Hellenic Medical Society
  • AWARD
    Hippocratic Orator 2016
    28 Oct 2016
    The Hellenic Medical Society
  • GUEST LECTURE
    PGC-1α overexpression by lentiviral vector attenuates amyloid-β load and neuronal loss in an Alzheimer’s disease model
    1 Oct 2016
    European Society of Gene & Cell Therapy Congress
  • GUEST LECTURE
    Neuroprotection in an ALS mouse model following peripheral delivery of motor neuron targeted aCAR-IGF-1 Lentiviral vector
    19 Sep 2015
    ESGCT Congress
  • GUEST LECTURE
    AAV Vector Gene Therapy for Parkinson's Disease
    1 Apr 2014
    Department of Experimental Medical Science, Faculty of Medicine, Lund University
  • GUEST LECTURE
    Lentiviral Vectors: Clinical Trials for Neurodegenerative Diseases.
    1 Apr 2014
    Division of Brain Sciences seminar, Imperial College London
  • GUEST LECTURE
    “Gene-based Therapeutics for Neurological Disorders: From Basic Science to Clinical Applications” Fusion Conference Plenary lecture: Lentiviral Vectors: Prospect for Clinical Gene Therapy
    1 Feb 2014
  • EDITORIAL BOARD
    Frontiers in Cellular Neuroscience
    1 Feb 2014 - 5 Feb 2021
    Review Editor
  • GUEST LECTURE
    Lentiviral vector based gene therapy in the fight against neurodegenerative diseases
    9 Nov 2013
    1st International Multithematic Medical Congress "Bio-Medical Scientific Cyprus", School of Medicine, European University of Cyprus
  • AWARD
    Rector's Gold Medal
    9 Nov 2013
    European University of Cyprus
  • GUEST LECTURE
    Thy1.1, p75NTR or CAR receptor targeting by lentiviral vectors leads to retrograde transport and transduction of spinal motor neurons following peripheral delivery.
    1 Oct 2013
    ESGCT/SETGC collaborative Congress
  • GUEST LECTURE
    Challenges in Translational Medicine TRANSMED Conference "Translational gene therapy approaches for neurodegenerative diseases using lentiviral vectors"
    1 Apr 2013
    Biomedical Research Foundation of the Academy of Athens
  • MEMBERSHIP OF A PROFESSIONAL BODY
    Academic
    1 Jan 2013
    2013-01-01 - European Society of Gene and Cell Therapy
  • MEMBERSHIP OF A PROFESSIONAL BODY
    Associate Member
    1 Jan 2013
    2013-01-01 - American Society for Gene and Cell Therapy
  • GUEST LECTURE
    Gene Therapy Approaches for Parkinson’s Disease,
    1 Nov 2012
    Mitchell Lewis Seminar Series, Department of Haematology Imperial College Faculty of Medicine
  • GUEST LECTURE
    Gene Therapy for Parkinson’s Disease.
    1 Nov 2012
    Neuroméditerranée XII Congress, Institute of Neurology
  • GUEST LECTURE
    Gene Therapy for Parkinson’s Disease.
    1 Jul 2012
    Academic Neuroscience Guest Lecture, Charing Cross Hospital
  • GUEST LECTURE
    Gene Therapy for Parkinson’s Disease
    1 Feb 2012
    Cambridge Neurological Society
  • EXTERNAL COMMITTEE
    Prix Galien Greece
    1 Jan 2012
  • GUEST LECTURE
    Enhanced pseudotyping efficiency of HIV-1 lentiviral vectors by a rabies/Vesicular stomatitis virus chimeric envelope glycoprotein
    1 Oct 2011
    European Society of Gene and Cell Therapy & British Society for Gene Therapy Collaborative Congress
  • EDITORIAL BOARD
    JAK-STAT
    1 Jan 2011
    editorial board member